{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:25:06Z","timestamp":1792855506778,"version":"4.5.0"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.cyto.2017.06.016","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T00:04:07Z","timestamp":1498521847000},"page":"154089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Interleukin 17A in atherosclerosis \u2013 Regulation and pathophysiologic effector function"],"prefix":"10.1016","volume":"122","author":[{"given":"Johannes","family":"Nordlohne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"von Vietinghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0005","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/ATVBAHA.114.303567","article-title":"IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles","volume":"35","author":"Taleb","year":"2014","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cyto.2015.03.009","article-title":"Regulation of IL-17 in atherosclerosis and related autoimmunity","volume":"74","author":"Ryu","year":"2015","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.cyto.2017.06.016_b0015","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/eurheartj\/ehs399","article-title":"Interleukin-17 in atherosclerosis and cardiovascular disease: the good, the bad, and the unknown","volume":"34","author":"Liuzzo","year":"2013","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.cyto.2017.06.016_b0020","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cytogfr.2010.10.003","article-title":"Interleukin 17 in vascular inflammation","volume":"21","author":"von Vietinghoff","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional specialization of interleukin-17 family members","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.cyto.2017.06.016_b0030","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1161\/ATVBAHA.111.227629","article-title":"Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice","volume":"31","author":"Madhur","year":"2011","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"issue":"15","key":"10.1016\/j.cyto.2017.06.016_b0035","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/CIRCULATIONAHA.109.924886","article-title":"Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice","volume":"121","author":"Smith","year":"2010","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cyto.2017.06.016_b0040","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1161\/ATVBAHA.116.307892","article-title":"Smooth muscle cell-derived interleukin-17C plays an atherogenic role via the recruitment of proinflammatory interleukin-17A+ T cells to the aorta","volume":"36","author":"Butcher","year":"2016","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0045","doi-asserted-by":"crossref","first-page":"e0117255","DOI":"10.1371\/journal.pone.0117255","article-title":"IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice","volume":"10","author":"Mantani","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0050","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4049\/jimmunol.175.1.404","article-title":"Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis","volume":"175","author":"McAllister","year":"2005","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2017.06.016_b0055","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2017.06.016_b0060","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic inflammation","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4049\/jimmunol.177.1.36","article-title":"Cutting edge: interleukin 17 signals through a heteromeric receptor complex","volume":"177","author":"Toy","year":"2006","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2017.06.016_b0070","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2017.06.016_b0075","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1128\/IAI.05493-11","article-title":"Neutrophils produce interleukin 17A (IL-17A) in a dectin-1- and IL-23-dependent manner during invasive fungal infection","volume":"79","author":"Werner","year":"2011","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ni.2797","article-title":"Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORgammat and dectin-2","volume":"15","author":"Taylor","year":"2014","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2017.06.016_b0085","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.4049\/jimmunol.0900887","article-title":"T-lineage cells require the thymus but not VDJ recombination to produce IL-17A and regulate granulopoiesis in vivo","volume":"183","author":"Smith","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2017.06.016_b0090","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1038\/emm.2015.19","article-title":"The enhanced expression of IL-17-secreting T cells during the early progression of atherosclerosis in ApoE-deficient mice fed on a western-type diet","volume":"47","author":"Jeon","year":"2015","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0095","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cyto.2009.09.007","article-title":"The Th17\/Treg functional imbalance during atherogenesis in ApoE(-\/-) mice","volume":"49","author":"Xie","year":"2010","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.cyto.2017.06.016_b0100","doi-asserted-by":"crossref","first-page":"e109416","DOI":"10.1371\/journal.pone.0109416","article-title":"gammadeltaT cells are prevalent in the proximal aorta and drive nascent atherosclerotic lesion progression and neutrophilia in hypercholesterolemic mice","volume":"9","author":"Vu","year":"2014","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J. Exp. Med."},{"issue":"7090","key":"10.1016\/j.cyto.2017.06.016_b0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"7090","key":"10.1016\/j.cyto.2017.06.016_b0115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-beta induces development of the T(H)17 lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.cyto.2017.06.016_b0125","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/ni.3742","article-title":"Interleukin 17 is a chief orchestrator of immunity","volume":"18","author":"Veldhoen","year":"2017","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/imr.12035","article-title":"The Th17 family: flexibility follows function","volume":"252","author":"Basu","year":"2013","journal-title":"Immunol. Rev."},{"issue":"13","key":"10.1016\/j.cyto.2017.06.016_b0135","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1182\/blood-2012-09-378653","article-title":"Essentials of Th17 cell commitment and plasticity","volume":"121","author":"Muranski","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0140","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/imr.12036","article-title":"Th17 cell development: from the cradle to the grave","volume":"252","author":"Zuniga","year":"2013","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cell.2012.09.016","article-title":"A validated regulatory network for Th17 cell specification","volume":"151","author":"Ciofani","year":"2012","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.cyto.2017.06.016_b0150","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/CIRCRESAHA.112.277525","article-title":"Interleukin-27 receptor limits atherosclerosis in Ldlr-\/- mice","volume":"111","author":"Koltsova","year":"2012","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0155","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1161\/CIRCRESAHA.116.304794","article-title":"Identification of a non-growth factor role for GM-CSF in advanced atherosclerosis: promotion of macrophage apoptosis and plaque necrosis through IL-23 signaling","volume":"116","author":"Subramanian","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.cyto.2017.06.016_b0160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev-pathol-020712-163936","article-title":"The influence of innate and adaptive immune responses on atherosclerosis","volume":"9","author":"Witztum","year":"2014","journal-title":"Ann. Rev. Pathol."},{"issue":"6245","key":"10.1016\/j.cyto.2017.06.016_b0165","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.aaa8064","article-title":"Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis","volume":"349","author":"Warnatsch","year":"2015","journal-title":"Science"},{"issue":"28","key":"10.1016\/j.cyto.2017.06.016_b0170","doi-asserted-by":"crossref","first-page":"9721","DOI":"10.1073\/pnas.0804231105","article-title":"Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells","volume":"105","author":"Kimura","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7191","key":"10.1016\/j.cyto.2017.06.016_b0175","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature06881","article-title":"The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins","volume":"453","author":"Veldhoen","year":"2008","journal-title":"Nature"},{"issue":"7191","key":"10.1016\/j.cyto.2017.06.016_b0180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature06880","article-title":"Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor","volume":"453","author":"Quintana","year":"2008","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.cyto.2017.06.016_b0185","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/CIRCGENETICS.115.001097","article-title":"DNA methylation of the aryl hydrocarbon receptor repressor associations with cigarette smoking and subclinical atherosclerosis","volume":"8","author":"Reynolds","year":"2015","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"6","key":"10.1016\/j.cyto.2017.06.016_b0190","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/ATVBAHA.110.220202","article-title":"Activation of aryl hydrocarbon receptor induces vascular inflammation and promotes atherosclerosis in apolipoprotein E-\/- mice","volume":"31","author":"Wu","year":"2011","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0195","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.toxlet.2013.10.039","article-title":"AhR signalling and dioxin toxicity","volume":"230","author":"Sorg","year":"2014","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0200","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.canlet.2006.11.015","article-title":"Cigarette smoke as a trigger for the dioxin receptor-mediated signaling pathway","volume":"252","author":"Kitamura","year":"2007","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0205","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.imlet.2008.07.011","article-title":"Airway infiltration of CD4+ CCR6+ Th17 type cells associated with chronic cigarette smoke induced airspace enlargement","volume":"121","author":"Harrison","year":"2008","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cyto.2017.06.016_b0210","doi-asserted-by":"crossref","unstructured":"M. Shan, et al., Cigarette smoke induction of osteopontin (SPP1) mediates T(H)17 inflammation in human and experimental emphysema. Sci. Translational Med. 4(117) (2012) 117ra9.","DOI":"10.1126\/scitranslmed.3003041"},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0215","doi-asserted-by":"crossref","first-page":"268","DOI":"10.18632\/oncotarget.13613","article-title":"Impacts of cigarette smoking on immune responsiveness: Up and down or upside down?","volume":"8","author":"Qiu","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0220","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2008.08.001","article-title":"From the diet to the nucleus: vitamin A and TGF-beta join efforts at the mucosal interface of the intestine","volume":"21","author":"Mucida","year":"2009","journal-title":"Semin. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2017.06.016_b0225","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nri2378","article-title":"Vitamin effects on the immune system: vitamins A and D take centre stage","volume":"8","author":"Mora","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0230","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbalip.2011.07.001","article-title":"Retinoid metabolism and its effects on the vasculature","volume":"1821","author":"Rhee","year":"2012","journal-title":"Biochim. biophys. Acta"},{"issue":"17","key":"10.1016\/j.cyto.2017.06.016_b0235","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1128\/MCB.05020-11","article-title":"1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A","volume":"31","author":"Joshi","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cyto.2017.06.016_b0240","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1615783114","article-title":"Functional genomics analysis of vitamin D effects on CD4+ T cells in vivo in experimental autoimmune encephalomyelitis","author":"Zeitelhofer","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cyto.2017.06.016_b0245","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ijcard.2016.12.053","article-title":"Vitamin D and cardiovascular disease: From atherosclerosis to myocardial infarction and stroke","volume":"230","author":"Muscogiuri","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cyto.2017.06.016_b0250","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-med-051214-025146","article-title":"Vitamin D and cardiovascular disease","volume":"67","author":"Wang","year":"2016","journal-title":"Ann. Rev. Med."},{"key":"10.1016\/j.cyto.2017.06.016_b0255","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.atherosclerosis.2016.04.007","article-title":"Evidence for the vitamin D hypothesis: The NHANES III extended mortality follow-up","volume":"255","author":"Daraghmeh","year":"2016","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.cyto.2017.06.016_b0260","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.cell.2015.11.009","article-title":"Single-cell genomics unveils critical regulators of Th17 cell pathogenicity","volume":"163","author":"Gaublomme","year":"2015","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.cyto.2017.06.016_b0265","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.cell.2015.10.068","article-title":"CD5L\/AIM regulates lipid biosynthesis and restrains Th17 cell pathogenicity","volume":"163","author":"Wang","year":"2015","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.cyto.2017.06.016_b0270","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/nm.3704","article-title":"De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells","volume":"20","author":"Berod","year":"2014","journal-title":"Nat. Med."},{"issue":"33","key":"10.1016\/j.cyto.2017.06.016_b0275","doi-asserted-by":"crossref","first-page":"12163","DOI":"10.1073\/pnas.1322807111","article-title":"Oxysterols are agonist ligands of RORgammat and drive Th17 cell differentiation","volume":"111","author":"Soroosh","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cyto.2017.06.016_b0280","doi-asserted-by":"crossref","unstructured":"J. Frostegard, et al., Oxidized Low-Density Lipoprotein (OxLDL)-treated dendritic cells promote activation of T cells in human atherosclerotic plaque and blood, which is repressed by statins: microRNA let-7c Is integral to the effect. J. Am. Heart Assoc., 5(9) (2016).","DOI":"10.1161\/JAHA.116.003976"},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0285","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.immuni.2013.11.021","article-title":"Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo","volume":"40","author":"Lim","year":"2014","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0290","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/ATVBAHA.114.304342","article-title":"Induction of dendritic cell-mediated T-cell activation by modified but not native low-density lipoprotein in humans and inhibition by annexin a5: involvement of heat shock proteins","volume":"35","author":"Liu","year":"2015","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0295","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbrc.2012.02.117","article-title":"Interleukin-17 deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice","volume":"420","author":"Usui","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0300","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.atherosclerosis.2009.01.002","article-title":"oxLDL uptake by dendritic cells induces upregulation of scavenger-receptors, maturation and differentiation","volume":"205","author":"Nickel","year":"2009","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.cyto.2017.06.016_b0305","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1194\/jlr.M037861","article-title":"Unsaturated fatty acids prevent activation of NLRP3 inflammasome in human monocytes\/macrophages","volume":"54","author":"L'Homme","year":"2013","journal-title":"J. Lipid Res."},{"issue":"8","key":"10.1016\/j.cyto.2017.06.016_b0310","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1002\/eji.201546263","article-title":"Free fatty acids sensitize dendritic cells to amplify TH1\/TH17-immune responses","volume":"46","author":"Stelzner","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2017.06.016_b0315","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","article-title":"Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"issue":"7446","key":"10.1016\/j.cyto.2017.06.016_b0320","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature11868","article-title":"Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells","volume":"496","author":"Kleinewietfeld","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cyto.2017.06.016_b0325","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.cellsig.2013.11.031","article-title":"High glucose driven expression of pro-inflammatory cytokine and chemokine genes in lymphocytes: molecular mechanisms of IL-17 family gene expression","volume":"26","author":"Kumar","year":"2014","journal-title":"Cell. Signalling"},{"issue":"6","key":"10.1016\/j.cyto.2017.06.016_b0330","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.116.303697","article-title":"Inflammation, immunity, and hypertensive end-organ damage","volume":"116","author":"McMaster","year":"2015","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.cyto.2017.06.016_b0335","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1681\/ASN.2015050562","article-title":"Immune mechanisms in arterial hypertension","volume":"27","author":"Wenzel","year":"2016","journal-title":"J. Am. Soc. Nephrol.: JASN"},{"issue":"3","key":"10.1016\/j.cyto.2017.06.016_b0340","doi-asserted-by":"crossref","first-page":"766","DOI":"10.4314\/ahs.v16i3.17","article-title":"Association of interleukin 17\/angiotensin II with refractory hypertension risk in hemodialysis patients","volume":"16","author":"Wang","year":"2016","journal-title":"Afr. Health Sci."},{"issue":"10","key":"10.1016\/j.cyto.2017.06.016_b0345","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/jch.12612","article-title":"Elevated serum level of interleukin 17 in a population with prehypertension","volume":"17","author":"Yao","year":"2015","journal-title":"J. Clin. Hypertens."},{"issue":"12","key":"10.1016\/j.cyto.2017.06.016_b0350","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1161\/ATVBAHA.114.304108","article-title":"Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease","volume":"34","author":"Karbach","year":"2014","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"issue":"35","key":"10.1016\/j.cyto.2017.06.016_b0355","doi-asserted-by":"crossref","first-page":"14948","DOI":"10.1073\/pnas.0903958106","article-title":"Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity","volume":"106","author":"Platten","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"35","key":"10.1016\/j.cyto.2017.06.016_b0360","doi-asserted-by":"crossref","first-page":"14942","DOI":"10.1073\/pnas.0903602106","article-title":"Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system","volume":"106","author":"Stegbauer","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.cyto.2017.06.016_b0365","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/CIRCRESAHA.113.301934","article-title":"Increased atherosclerotic lesion formation and vascular leukocyte accumulation in renal impairment are mediated by interleukin-17A","volume":"113","author":"Ge","year":"2013","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0370","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","article-title":"Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction","volume":"55","author":"Madhur","year":"2010","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.cyto.2017.06.016_b0375","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/HYPERTENSIONAHA.113.02620","article-title":"Deficiency of the interleukin 17\/23 axis accelerates renal injury in mice with deoxycorticosterone acetate+angiotensin II-induced hypertension","volume":"63","author":"Krebs","year":"2013","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.cyto.2017.06.016_b0380","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.annepidem.2003.11.002","article-title":"Associations between white blood cell count and risk for cerebrovascular disease mortality: NHANES II mortality study, 1976\u20131992","volume":"14","author":"Brown","year":"2004","journal-title":"Annals of epidemiology"},{"issue":"5","key":"10.1016\/j.cyto.2017.06.016_b0385","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/archinte.165.5.500","article-title":"Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study","volume":"165","author":"Margolis","year":"2005","journal-title":"Arch. Intern. Med."},{"issue":"9","key":"10.1016\/j.cyto.2017.06.016_b0390","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jacc.2015.12.048","article-title":"Leukocytes link local and systemic inflammation in ischemic cardiovascular disease: an expanded \u201ccardiovascular continuum\u201d","volume":"67","author":"Libby","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.cyto.2017.06.016_b0395","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.4049\/jimmunol.181.8.5183","article-title":"Homeostatic regulation of blood neutrophil counts","volume":"181","author":"von Vietinghoff","year":"2008","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2017.06.016_b0400","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1172\/JCI78085","article-title":"Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity","volume":"125","author":"Burkett","year":"2015","journal-title":"J. Clin. Investigat."},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0405","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00296-016-3487-2","article-title":"Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms","volume":"37","author":"Yim","year":"2017","journal-title":"Rheumatol. Int."},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0410","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12895-016-0046-1","article-title":"Effect of 12-O-tetradecanoylphorbol-13-acetate-induced psoriasis-like skin lesions on systemic inflammation and atherosclerosis in hypercholesterolaemic apolipoprotein E deficient mice","volume":"16","author":"Madsen","year":"2016","journal-title":"BMC Dermatol."},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0415","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/joim.12529","article-title":"Systemic lupus erythematosus: still a challenge for physicians","volume":"281","author":"Bengtsson","year":"2017","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cyto.2017.06.016_b0420","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3389\/fimmu.2015.00610","article-title":"Disturbed T cell signaling and altered Th17 and regulatory T cell subsets in the pathogenesis of systemic lupus erythematosus","volume":"6","author":"Rother","year":"2015","journal-title":"Frontiers Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2017.06.016_b0425","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/NRL.0000000000000064","article-title":"Cardiovascular dysfunction in multiple sclerosis","volume":"20","author":"Kaplan","year":"2015","journal-title":"Neurologist"},{"issue":"6","key":"10.1016\/j.cyto.2017.06.016_b0430","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ki.2011.223","article-title":"Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Herzog","year":"2011","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.cyto.2017.06.016_b0435","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ki.2010.536","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts","volume":"79","author":"van der Velde","year":"2011","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0440","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ki.2013.111","article-title":"Chronic kidney disease is associated with neovascularization and intraplaque hemorrhage in coronary atherosclerosis in elders: results from the Hisayama study","volume":"84","author":"Nakano","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.cyto.2017.06.016_b0445","article-title":"Increased arterial inflammation in individuals with stage 3 chronic kidney disease","author":"Takx","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"6","key":"10.1016\/j.cyto.2017.06.016_b0450","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1681\/ASN.2015050540","article-title":"T Cell CX3CR1 mediates excess atherosclerotic inflammation in renal impairment","volume":"27","author":"Dong","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"12 Suppl 3","key":"10.1016\/j.cyto.2017.06.016_b0455","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1681\/ASN.2006080910","article-title":"Dissecting inflammation in ESRD: do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients?","volume":"17","author":"Zoccali","year":"2006","journal-title":"J. Am. Soc. Nephrol.: JASN"},{"issue":"6","key":"10.1016\/j.cyto.2017.06.016_b0460","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3109\/0886022X.2012.672155","article-title":"Treg\/Th17 functional disequilibrium in Chinese uremia on hemodialysis: a link between calcification and cardiovascular disease","volume":"34","author":"Chen","year":"2012","journal-title":"Ren. Fail."},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0465","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1440-1797.2009.01172.x","article-title":"Regulatory T cells\/T-helper cell 17 functional imbalance in uraemic patients on maintenance haemodialysis: a pivotal link between microinflammation and adverse cardiovascular events","volume":"15","author":"Zhang","year":"2010","journal-title":"Nephrology (Carlton)"},{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0470","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.imlet.2011.10.002","article-title":"Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients","volume":"141","author":"Chung","year":"2012","journal-title":"Immunol. Lett."},{"issue":"4","key":"10.1016\/j.cyto.2017.06.016_b0475","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/ki.2015.200","article-title":"Th-17 cell activation in response to high salt following acute kidney injury is associated with progressive fibrosis and attenuated by AT-1R antagonism","volume":"88","author":"Mehrotra","year":"2015","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.cyto.2017.06.016_b0480","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3390\/toxins6030934","article-title":"The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease","volume":"6","author":"Sallee","year":"2014","journal-title":"Toxins"},{"key":"10.1016\/j.cyto.2017.06.016_b0485","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2741\/4363","article-title":"Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation","volume":"20","author":"Wang","year":"2015","journal-title":"Frontiers Biosci."},{"issue":"7","key":"10.1016\/j.cyto.2017.06.016_b0490","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/eji.201242779","article-title":"Kynurenine 3-monooxygenase mediates inhibition of Th17 differentiation via catabolism of endogenous aryl hydrocarbon receptor ligands","volume":"43","author":"Stephens","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2017.06.016_b0495","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/art.24446","article-title":"Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1\/Th17 cells in the joint in collagen-induced arthritis","volume":"60","author":"Criado","year":"2009","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.cyto.2017.06.016_b0500","unstructured":"D. Favre, et al., Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci. Translational Med. 2(32) (2010) 32ra36."},{"issue":"42","key":"10.1016\/j.cyto.2017.06.016_b0505","doi-asserted-by":"crossref","first-page":"13033","DOI":"10.1073\/pnas.1517820112","article-title":"Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development","volume":"112","author":"Cole","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0510","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2015.08.061","article-title":"An IL-23R\/IL-22 circuit regulates epithelial serum amyloid a to promote local effector Th17 responses","volume":"163","author":"Sano","year":"2015","journal-title":"Cell"},{"issue":"43","key":"10.1016\/j.cyto.2017.06.016_b0515","first-page":"3007","article-title":"Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk","volume":"36","author":"Zewinger","year":"2015","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.cyto.2017.06.016_b0520","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCRESAHA.111.261784","article-title":"The IL-17A\/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment","volume":"110","author":"Butcher","year":"2012","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0525","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/ATVBAHA.111.229997","article-title":"Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice","volume":"32","author":"Danzaki","year":"2011","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"issue":"9","key":"10.1016\/j.cyto.2017.06.016_b0530","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.4049\/jimmunol.1001879","article-title":"IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice","volume":"185","author":"Chen","year":"2010","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0535","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.atherosclerosis.2010.12.034","article-title":"Inhibition of IL-17A in atherosclerosis","volume":"215","author":"Cheng","year":"2011","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0540","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbrc.2009.07.152","article-title":"Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice","volume":"388","author":"van Es","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.cyto.2017.06.016_b0545","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.4049\/jimmunol.0901126","article-title":"Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice","volume":"183","author":"Erbel","year":"2009","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2017.06.016_b0550","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.4049\/jimmunol.1400181","article-title":"IL-17A influences essential functions of the monocyte\/macrophage lineage and is involved in advanced murine and human atherosclerosis","volume":"193","author":"Erbel","year":"2014","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2017.06.016_b0555","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.4049\/jimmunol.1000116","article-title":"A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice","volume":"185","author":"Gao","year":"2010","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2017.06.016_b0560","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1084\/jem.20090545","article-title":"Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis","volume":"206","author":"Taleb","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2017.06.016_b0565","doi-asserted-by":"crossref","unstructured":"A. Gistera, et al., Transforming growth factor-beta signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway. Sci. Translational Med. 5(196) (2013) 196ra100.","DOI":"10.1126\/scitranslmed.3006133"},{"issue":"9","key":"10.1016\/j.cyto.2017.06.016_b0570","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/CIRCRESAHA.110.221069","article-title":"Interleukin-17-dependent autoimmunity to collagen type V in atherosclerosis","volume":"107","author":"Dart","year":"2010","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.cyto.2017.06.016_b0575","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/annrheumdis-2013-203759","article-title":"Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-\/- mice","volume":"74","author":"Wilhelm","year":"2015","journal-title":"Ann. Rheumatic Diseases"},{"key":"10.1016\/j.cyto.2017.06.016_b0580","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yjmcc.2014.02.005","article-title":"Allergic asthma accelerates atherosclerosis dependent on Th2 and Th17 in apolipoprotein E deficient mice","volume":"72","author":"Wang","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"9","key":"10.1016\/j.cyto.2017.06.016_b0585","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/bph.13453","article-title":"Digoxin reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"173","author":"Shi","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"21","key":"10.1016\/j.cyto.2017.06.016_b0590","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.jacc.2010.12.030","article-title":"Mycophenolate mofetil decreases atherosclerotic lesion size by depression of aortic T-lymphocyte and interleukin-17-mediated macrophage accumulation","volume":"57","author":"von Vietinghoff","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cyto.2017.06.016_b0595","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2119\/molmed.2014.00195","article-title":"Valsartan attenuates atherosclerosis via upregulating the Th2 immune response in prolonged angiotensin II-treated ApoE(-\/-) mice","volume":"21","author":"Meng","year":"2015","journal-title":"Mol. Med."},{"issue":"4","key":"10.1016\/j.cyto.2017.06.016_b0600","doi-asserted-by":"crossref","first-page":"345","DOI":"10.12998\/wjcc.v3.i4.345","article-title":"Atherosclerosis and the role of immune cells","volume":"3","author":"Ilhan","year":"2015","journal-title":"World J. Clin. Cases"},{"issue":"11","key":"10.1016\/j.cyto.2017.06.016_b0605","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.cyto.2017.06.016_b0610","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/MOL.0b013e328363d298","article-title":"Myeloid cells in atherosclerosis: a delicate balance of anti-inflammatory and proinflammatory mechanisms","volume":"24","author":"Koltsova","year":"2013","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.cyto.2017.06.016_b0615","doi-asserted-by":"crossref","unstructured":"S.H. Karbach, et al., Gut microbiota promote angiotensin II-induced arterial hypertension and vascular dysfunction. J. Am. Heart Assoc. 5(9) (2016).","DOI":"10.1161\/JAHA.116.003698"},{"issue":"3","key":"10.1016\/j.cyto.2017.06.016_b0620","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/eji.201141737","article-title":"Macrophages participate in IL-17-mediated inflammation","volume":"42","author":"Barin","year":"2012","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0625","doi-asserted-by":"crossref","first-page":"e85461","DOI":"10.1371\/journal.pone.0085461","article-title":"Interleukin 17 receptor A modulates monocyte subsets and macrophage generation in vivo","volume":"9","author":"Ge","year":"2014","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.cyto.2017.06.016_b0630","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2016.03.017","article-title":"Innate lymphocyte\/Ly6C(hi) monocyte crosstalk promotes klebsiella pneumoniae clearance","volume":"165","author":"Xiong","year":"2016","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.cyto.2017.06.016_b0635","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.4049\/jimmunol.0901942","article-title":"IL-17-mediated monocyte migration occurs partially through CC chemokine ligand 2\/monocyte chemoattractant protein-1 induction","volume":"184","author":"Shahrara","year":"2010","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2017.06.016_b0640","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2567.2009.03240.x","article-title":"Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease","volume":"129","author":"Onishi","year":"2010","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.cyto.2017.06.016_b0645","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1194\/jlr.M054874","article-title":"Human monocyte-derived dendritic cells turn into foamy dendritic cells with IL-17A","volume":"56","author":"Salvatore","year":"2015","journal-title":"J. Lipid Res."},{"issue":"10","key":"10.1016\/j.cyto.2017.06.016_b0650","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1074\/jbc.M115.690081","article-title":"Interleukin-17A promotes aortic endothelial cell activation via transcriptionally and post-translationally activating p38 mitogen-activated protein kinase (MAPK) pathway","volume":"291","author":"Mai","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.cyto.2017.06.016_b0655","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.4049\/jimmunol.1600138","article-title":"IL-17 promotes neutrophil-mediated immunity by activating microvascular pericytes and not endothelium","volume":"197","author":"Liu","year":"2016","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0660","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/HYPERTENSIONAHA.116.07493","article-title":"Interleukin-17A regulates renal sodium transporters and renal injury in angiotensin II-induced hypertension","volume":"68","author":"Norlander","year":"2016","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.cyto.2017.06.016_b0665","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/HYPERTENSIONAHA.114.04975","article-title":"Renal transporter activation during angiotensin-II hypertension is blunted in interferon-gamma-\/- and interleukin-17A\u2212\/\u2212 mice","volume":"65","author":"Kamat","year":"2015","journal-title":"Hypertension"},{"issue":"7639","key":"10.1016\/j.cyto.2017.06.016_b0670","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature20818","article-title":"IL-17 is a neuromodulator of caenorhabditis elegans sensory responses","volume":"542","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2017.06.016_b0675","doi-asserted-by":"crossref","unstructured":"O.J. de Boer, et al., Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques. J. Pathol. (2009) n\/a\u2013n\/a.","DOI":"10.1002\/path.2667"},{"issue":"10","key":"10.1016\/j.cyto.2017.06.016_b0680","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.108.827618","article-title":"Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells","volume":"119","author":"Eid","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0685","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00395-010-0135-y","article-title":"Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability","volume":"106","author":"Erbel","year":"2011","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.cyto.2017.06.016_b0690","first-page":"1","article-title":"Regulatory T CD4 + CD25+ lymphocytes increase in symptomatic carotid artery stenosis","author":"Del Porto","year":"2016","journal-title":"Ann. Med."},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0695","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2014.10.088","article-title":"Treg\/Th17 balance in stable CAD patients with different stages of coronary atherosclerosis","volume":"238","author":"Potekhina","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cyto.2017.06.016_b0700","doi-asserted-by":"crossref","unstructured":"Z.D. Liu, et al., Increased Th17 cell frequency concomitant with decreased Foxp3+ Treg cell frequency in the peripheral circulation of patients with carotid artery plaques. Inflammation Res.: Official J. Eur. Histamine Res. Soc. 61(10) (2012) 1155\u20131165.","DOI":"10.1007\/s00011-012-0510-2"},{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0705","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.atherosclerosis.2011.03.043","article-title":"Activation of Th17\/Th1 and Th1, but not Th17, is associated with the acute cardiac event in patients with acute coronary syndrome","volume":"217","author":"Zhao","year":"2011","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.cyto.2017.06.016_b0710","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/cmi.2011.22","article-title":"The altered expression of inflammation-related microRNAs with microRNA-155 expression correlates with Th17 differentiation in patients with acute coronary syndrome","volume":"8","author":"Yao","year":"2011","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2017.06.016_b0715","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","article-title":"The Th17\/Treg imbalance in patients with acute coronary syndrome","volume":"127","author":"Cheng","year":"2008","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2017.06.016_b0720","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.bbrc.2010.03.090","article-title":"The role of oxidized low-density lipoprotein in breaking peripheral Th17\/Treg balance in patients with acute coronary syndrome","volume":"394","author":"Li","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.cyto.2017.06.016_b0725","doi-asserted-by":"crossref","first-page":"e71466","DOI":"10.1371\/journal.pone.0071466","article-title":"Elevated frequencies of circulating Th22 cell in addition to Th17 cell and Th17\/Th1 cell in patients with acute coronary syndrome","volume":"8","author":"Zhang","year":"2013","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.cyto.2017.06.016_b0730","first-page":"297","article-title":"Distinct different sensitivity of Treg and Th17 cells to Fas-mediated apoptosis signaling in patients with acute coronary syndrome","volume":"6","author":"Li","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.cyto.2017.06.016_b0735","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1177\/147323000903700331","article-title":"Myeloperoxidase (MPO) and interleukin-17 (IL-17) plasma levels are increased in patients with acute coronary syndromes","volume":"37","author":"Liang","year":"2009","journal-title":"J. Int. Med. Res."},{"issue":"8","key":"10.1016\/j.cyto.2017.06.016_b0740","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/eurheartj\/ehs263","article-title":"Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction","volume":"34","author":"Simon","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cyto.2017.06.016_b0745","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2017.00001","article-title":"Upregulation of TH\/IL-17 pathway-related genes in human coronary endothelial cells stimulated with serum of patients with acute coronary syndromes","volume":"4","author":"Cimmino","year":"2017","journal-title":"Frontiers Cardiovasc. Med."},{"key":"10.1016\/j.cyto.2017.06.016_b0750","article-title":"Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomised controlled trials","author":"Rungapiromnan","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cyto.2017.06.016_b0755","doi-asserted-by":"crossref","unstructured":"R. Khanna, et al., Anti-IL-12\/23p40 antibodies for induction of remission in Crohn's disease. The Cochrane Database Systematic Rev., 5 (2015) CD007572.","DOI":"10.1002\/14651858.CD007572.pub2"},{"issue":"8","key":"10.1016\/j.cyto.2017.06.016_b0760","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/jama.2011.1211","article-title":"Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials","volume":"306","author":"Ryan","year":"2011","journal-title":"JAMA"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617301886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617301886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:53:19Z","timestamp":1760907199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466617301886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":152,"alternative-id":["S1043466617301886"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2017.06.016","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin 17A in atherosclerosis \u2013 Regulation and pathophysiologic effector function","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2017.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154089"}}